ARWRVSAXTI• 12 Months (Normalized)
ARWR vs AXTI (Arrowhead Pharmaceuticals Inc. vs AXT Inc)
Showing Closing Date Range from Sep, 11, 2025 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARWR Performance $82.85
+178.77%
Arrowhead Pharmaceuticals Inc.
Normalized Baseline0.00%
AXTI Performance $64.77
+1810.62%
AXT Inc
Normalized Baseline0.00%
Alpha Spread Margin AXTI LEADS
-1631.85%
AXTI outperforming by 1631.85%
ARWRAXTI
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARWR AXTI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | ARWR Price | ARWR Gain (%) | AXTI Price | AXTI Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $82.85 | +178.77% | $64.77 | +1810.62% | -1631.85% |
| Sep 10, 2026 | $82.76 | +178.47% | $64.70 | +1808.55% | -1630.08% |
| Sep 09, 2026 | $82.63 | +178.03% | $68.91 | +1932.74% | -1754.71% |
| Sep 08, 2026 | $85.11 | +186.37% | $69.56 | +1951.92% | -1765.55% |
| Sep 04, 2026 | $86.34 | +190.51% | $61.64 | +1718.29% | -1527.78% |
| Sep 03, 2026 | $86.49 | +191.02% | $56.20 | +1557.82% | -1366.80% |
| Sep 02, 2026 | $85.37 | +187.25% | $56.95 | +1579.94% | -1392.69% |
| Sep 01, 2026 | $82.74 | +178.40% | $56.11 | +1555.16% | -1376.76% |
| Aug 31, 2026 | $82.39 | +177.22% | $60.61 | +1687.91% | -1510.69% |
| Aug 28, 2026 | $84.91 | +185.70% | $58.63 | +1629.50% | -1443.80% |
| Aug 27, 2026 | $88.59 | +198.08% | $66.92 | +1874.04% | -1675.96% |
| Aug 26, 2026 | $89.12 | +199.87% | $65.18 | +1822.71% | -1622.84% |
| Aug 25, 2026 | $88.88 | +199.06% | $67.45 | +1889.68% | -1690.62% |
| Aug 24, 2026 | $86.73 | +191.82% | $65.40 | +1829.20% | -1637.38% |
| Aug 21, 2026 | $87.11 | +193.10% | $70.74 | +1986.73% | -1793.63% |
Page 1 of 17